plerixafor has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badros, AZ; Hardy, N; Kocoglu, M; Rapoport, AP; Rybinski, B | 1 |
1 other study(ies) available for plerixafor and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era.
Topics: Benzylamines; COVID-19; Cyclams; Cyclophosphamide; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lenalidomide; Multiple Myeloma; Pandemics; Retrospective Studies; Transplantation, Autologous | 2022 |